Pharma's Middle Management Challenge The challenge for senior leadership is to enable the layers of middle management to work to their full potential. Mike Straw argues that ‘failing fast’ should become the new mantra if pharma is going to drive greater innovation and creativity... Read more
US Legislators Urge More Incentives for Ebola Drug Development US Senators are proposing legislation to add Ebola to the list of diseases eligible for priority review vouchers from the FDA as an incentive for biopharma companies to invest in treatments for this deadly disease. Jill Wechsler reports... Read more
EMA's Rapid Feedback on GSK’s Ebola Vaccine For the first time in the current Ebola outbreak, the European Medicines Agency (EMA) has given ‘rapid scientific advice’ using an accelerated procedure to GSK on its development plan for an Ebola vaccine... Read more
Dane in America: An Interview with Novo Nordisk’s Jesper Hoiland Novo Nordisk’s Senior Vice President for North America, Jesper Hoiland, talks about his first year on the job at Novo’s regional headquarters in Princeton, New Jersey, including an unsettling encounter with the growing clout of pharmacy benefit manager medicines gatekeepers and observations on the importance of stakeholder outreach in a health system driven largely by relationships .... Read more
